Your browser doesn't support javascript.
loading
Overcoming Low Adherence to Chronic Medications by Improving their Effectiveness using a Personalized Second-generation Digital System.
Bayatra, Areej; Nasserat, Rima; Ilan, Yaron.
Affiliation
  • Bayatra A; Department of Medicine, the Hebrew University-Hadassah Medical Center, Jerusalem, Israel.
  • Nasserat R; Department of Medicine, the Hebrew University-Hadassah Medical Center, Jerusalem, Israel.
  • Ilan Y; Department of Medicine, the Hebrew University-Hadassah Medical Center, Jerusalem, Israel.
Curr Pharm Biotechnol ; 25(16): 2078-2088, 2024.
Article in En | MEDLINE | ID: mdl-38288794
ABSTRACT

INTRODUCTION:

Low adherence to chronic treatment regimens is a significant barrier to improving clinical outcomes in patients with chronic diseases. Low adherence is a result of multiple factors.

METHODS:

We review the relevant studies on the prevalence of low adherence and present some potential solutions.

RESULTS:

This review presents studies on the current measures taken to overcome low adherence, indicating a need for better methods to deal with this problem. The use of first-generation digital systems to improve adherence is mainly based on reminding patients to take their medications, which is one of the reasons they fail to provide a solution for many patients. The establishment of a second-generation artificial intelligence system, which aims to improve the effectiveness of chronic drugs, is described.

CONCLUSION:

Improving clinically meaningful outcome measures and disease parameters may increase adherence and improve patients' response to therapy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Artificial Intelligence / Medication Adherence Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Curr Pharm Biotechnol Journal subject: BIOTECNOLOGIA / FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: Israel Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Artificial Intelligence / Medication Adherence Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Curr Pharm Biotechnol Journal subject: BIOTECNOLOGIA / FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: Israel Country of publication: Netherlands